Matthew Konneh
About Matthew Konneh
Matthew Konneh is the Director of Strategic Alliances Europe in Business Development at Celerion, where he has worked since 2018. He has extensive experience in the pharmaceutical industry, having held various leadership roles at companies such as Biotrial, Publicis Groupe, and Parexel.
Work at Celerion
Matthew Konneh serves as the Director of Strategic Alliances for Europe in Business Development at Celerion. He has held this position since 2018, contributing to the company's growth and strategic partnerships. His role involves fostering relationships with clients and stakeholders to enhance Celerion's presence in the European market. His client-focused approach is integral to his responsibilities, emphasizing the importance of building and maintaining strong client relationships.
Previous Experience in Business Development
Prior to his current role, Matthew Konneh accumulated extensive experience in business development and strategic alliances. He worked at Biotrial as Board Director and Director of Business Development from 2009 to 2018, where he played a key role in the company's operations in Rennes, Bretagne, France. His experience also includes serving as an Account Director at Publicis Groupe and as Senior Director of Client Services at Parexel, further solidifying his expertise in the pharmaceutical and healthcare sectors.
Educational Background
Matthew Konneh has a robust educational background in pharmacology and business management. He earned his Bachelor of Science in Pharmacology from King's College London from 1987 to 1991. He then pursued a Doctor of Philosophy in Pharmacology at Queen Mary University of London from 1991 to 1995. Additionally, he obtained a Master of Business Administration from Kingston University from 1999 to 2001, equipping him with a blend of scientific and managerial skills.
Expertise in Digital Health
Matthew Konneh possesses expertise in digital health, a rapidly evolving field that integrates technology with healthcare solutions. His knowledge in this area reflects his adaptability and forward-thinking approach within the pharmaceutical industry. This expertise is complemented by his demonstrated history of working across multiple therapeutic areas, showcasing his versatility and depth of understanding in various aspects of healthcare and pharmaceuticals.
Career History in the Pharmaceutical Industry
Matthew Konneh has a diverse career history in the pharmaceutical industry, beginning as a Research Scientist in Cardiovascular Pharmacology at Novartis in 1989. He has since held various roles that have contributed to his comprehensive understanding of the industry, including positions at Accenture and Symphony Health Solutions. His career trajectory illustrates his commitment to advancing healthcare through strategic business development and client engagement.